Master ultra-high-throughput screening principles. Learn how advanced automation and miniaturization accelerate drug ...
This article traces the history of high-throughput screening (HTS), describes key technological milestones, and examines the ...
Drug discovery can be a long and complex process. Medicines for neurodegenerative diseases like Alzheimer's disease are among the most expensive to develop, as animal model results have not proven to ...
Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...
High Throughput Screening Market to Reach USD 17,880 Million by 2031, Driven by Drug Discovery Advancements | Valuates Reports ...
To battle this epidemic, the National Institutes of Health (NIH) launched the Helping to End Addiction Long-term (HEAL) Initiative in 2018. As part of this effort, scientists at the NIH National ...
SCIEX launched the Echo ® MS+ system at SLAS 2024. According to the company, the system couples proprietary acoustic ejection mass spectrometry technology and open port interface (OPI) sampling with ...
DeepCyte, a techbio company building AI toxicology tools for drug development, launched today with $1.5 million in seed funding. The company is introducing two solutions to help biopharma teams detect ...
EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) today announced its participation in the 21 st Annual PEGS Boston – The Essential Protein & Antibody Engineering Summit underway at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results